Thomas R. Klumpp

3.6k total citations
58 papers, 1.7k citations indexed

About

Thomas R. Klumpp is a scholar working on Hematology, Oncology and Immunology. According to data from OpenAlex, Thomas R. Klumpp has authored 58 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Hematology, 12 papers in Oncology and 12 papers in Immunology. Recurrent topics in Thomas R. Klumpp's work include Hematopoietic Stem Cell Transplantation (34 papers), Acute Myeloid Leukemia Research (11 papers) and Multiple Myeloma Research and Treatments (8 papers). Thomas R. Klumpp is often cited by papers focused on Hematopoietic Stem Cell Transplantation (34 papers), Acute Myeloid Leukemia Research (11 papers) and Multiple Myeloma Research and Treatments (8 papers). Thomas R. Klumpp collaborates with scholars based in United States, Canada and Switzerland. Thomas R. Klumpp's co-authors include Kenneth F. Mangan, Michael A. Caligiuri, Robert J. Soiffer, Christine Murray, Hillard M. Lazarus, Christine Cameron, K Cochran, Edward A. Stadtmauer, Eunice S. Wang and Michael J. Robertson and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Investigation and Journal of Clinical Oncology.

In The Last Decade

Thomas R. Klumpp

51 papers receiving 1.6k citations

Peers

Countries citing papers authored by Thomas R. Klumpp

Since Specialization

Citations

This map shows the geographic impact of Thomas R. Klumpp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas R. Klumpp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas R. Klumpp more than expected).

Fields of papers citing papers by Thomas R. Klumpp

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas R. Klumpp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas R. Klumpp. The network helps show where Thomas R. Klumpp may publish in the future.

Co-authorship network of co-authors of Thomas R. Klumpp

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas R. Klumpp. A scholar is included among the top collaborators of Thomas R. Klumpp based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas R. Klumpp. Thomas R. Klumpp is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A prospective study of posttransplant cyclophosphamide for unrelated donor peripheral blood stem cell transplant with special attention to graft content and the impact of a higher γδ T cell dose 2024 ·European Journal Of Haematology ·(unknown), Benjamin E. Leiby, (unknown), Usama Gergis, (unknown), (unknown), Joanne Filicko-O’Hara, (unknown), Thomas R. Klumpp, Pierluigi Porcu, Neal Flomenberg, John L. Wagner	1
2	Cell Therapy Informatics: Updates on the Integration of HCT/IEC Functionalities into an Electronic Medical Record System in the US to Promote Efficiency, Patient Safety, Research, and Data Interoperability 2023 ·Transplantation and Cellular Therapy ·Vincent T. Ho, Thomas R. Klumpp, (unknown), (unknown), Mitchell E. Horwitz, Betty K. Hamilton, Kristin Page, Samantha Jaglowski, (unknown), Charles Martinez, (unknown), Allen Chen, Douglas Rizzo	1
3	A Phase I Trial of Sirolimus with “7&3” Induction Chemotherapy in Patients with Newly Diagnosed Acute Myeloid Leukemia 2023 ·Cancers ·Neil Palmisiano, Grace R. Jeschke, Lindsay Wilde, Önder Alpdoğan, Matthew Carabasi, Joanne Filicko-O’Hara, Dolores Grosso, Thomas R. Klumpp, (unknown), John L. Wagner, Martin Carroll, Alexander E. Perl, Margaret Kasner	0
4	A Prospective, Randomized Trial Examining the Use of G-CSF Versus No G-CSF in Patients Post-Autologous Transplantation 2022 ·Transplantation and Cellular Therapy ·Dolores Grosso, Benjamin E. Leiby, Lindsay Wilde, Matthew Carabasi, Joanne Filicko-O’Hara, (unknown), John L. Wagner, (unknown), Önder Alpdoğan, Adam Binder, Margaret Kasner, (unknown), Thomas R. Klumpp, (unknown), Neil Palmisiano, Pierluigi Porcu, Usama Gergis, Neal Flomenberg	3
5	Case Report: Concomitant Diagnosis of Plasma Cell Leukemia in Patient With JAK2 Positive Myeloproliferative Neoplasm 2020 ·Frontiers in Oncology ·(unknown), Colin Thomas, (unknown), Thomas R. Klumpp, Adam Binder	0
6	Autologous Stem Cell Transplantation for Multiple Myeloma: Growth Factor Matters 2019 ·Biology of Blood and Marrow Transplantation ·Jason Chen, (unknown), Tingting Zhan, Sherilyn A. Tuazon, Neeraj Saini, (unknown), Joanne Filicko-O’Hara, Thomas R. Klumpp, Margaret Kasner, Matthew Carabasi, Pierluigi Porcu, John L. Wagner	6
7	Factors Affecting Platelet Transfusion Response Following Haploidentical Stem Cell Transplant 2017 ·Blood ·(unknown), (unknown), Jason Chen, (unknown), Vincent Yeung, (unknown), Inna Chervoneva, Dolores Grosso, Jay H. Herman, Neal Flomenberg, Thomas R. Klumpp	0
8	The Presence of Recipient CMV Immunodominant Human Leukocyte Antigen (HLA) Alleles Affect Outcomes after Haploidentical (HI) Hematopoietic Stem Cell Transplantation (HSCT) 2017 ·Blood ·Dolores Grosso, Önder Alpdoğan, (unknown), Joanne Filicko-O’Hara, Sameh Gaballa, Margaret Kasner, Thomas R. Klumpp, Ubaldo Martinez‐Outschoorn, (unknown), Neil Palmisiano, John L. Wagner, Pierluigi Porcu, Neal Flomenberg	1
9	A Phase II Study of Azacitidine and Sirolimus for the Treatment of Acute Myeloid Leukemia (AML) Refractory to or Not Eligible for Intensive Chemotherapy or High Risk Myelodysplastic Syndrome (MDS) 2017 ·Blood ·Neil Palmisiano, Grace R. Jeschke, Lindsay Wilde, Benjamin E. Leiby, Önder Alpdoğan, (unknown), Joanne Filicko-O’Hara, Sameh Gaballa, Dolores Grosso, Thomas R. Klumpp, (unknown), John L. Wagner, Martin Carroll, Pierluigi Porcu, Neal Flomenberg, Alexander E. Perl, Margaret Kasner	1
10	Differences in Allogeneic Product T-Cell Subsets According to Donor Age: Associations with Immune Reconstitution and Acute Graft Versus Host Disease (aGVHD) in Haploidentical (HI) Hematopoietic Stem Cell Transplantation (HSCT) 2017 ·Blood ·Jason Chen, (unknown), John L. Wagner, Michael Sun, Önder Alpdoğan, Matthew Carabasi, Joanne Filicko-O’Hara, Sameh Gaballa, Margaret Kasner, Thomas R. Klumpp, Neil Palmisiano, Ubaldo Martinez‐Outschoorn, Pierluigi Porcu, Neal Flomenberg, Dolores Grosso	1
11	Electronic Medical Records and Quality of Cancer Care 2013 ·Current Oncology Reports ·Thomas R. Klumpp	7
12	ABO Blood Group Barrier in Allogeneic Bone Marrow Transplantation Revisited 2005 ·Biology of Blood and Marrow Transplantation ·Jörg D. Seebach, Georg Stüssi, Jakob Passweg, Fausto R. Loberiza, James Gajewski, Armand Keating, Martin Göerner, Philip A. Rowlings, Pierre Tiberghien, Gerald J. Elfenbein, Robert Peter Gale, Jon J. van Rood, Vijay Reddy, Éliane Gluckman, Brian J. Bolwell, Thomas R. Klumpp, Mary M. Horowitz, Olle Ringdén, A. John Barrett	96
13	Measurable immune dysfunction and telomere attrition in long-term allogeneic transplant recipients 2004 ·Bone Marrow Transplantation ·Nancy Lewis, (unknown), Kenneth F. Mangan, Thomas R. Klumpp, André Rogatko, Dominique Broccoli	18
14	Use of Ibritumomab Tiuxetan Anti-CD20 Radioimmunotherapy in a Non-Hodgkin's Lymphoma Patient Previously Treated with a Yttrium-90–Labeled Anti-CD22 Monoclonal Antibody 2003 ·Clinical Lymphoma ·Donald E. Tsai, Ivan Maillard, Stephen J. Schuster, Sunita D. Nasta, David L. Porter, Thomas R. Klumpp, David M. Goldenberg, Selina M. Luger, Abass Alavi, Robert M. Sharkey, (unknown), Edward A. Stadtmauer	7
15	Value of the pretransplant evaluation in predicting toxic day-100 mortality among blood stem-cell and bone marrow transplant recipients. 1998 ·Journal of Clinical Oncology ·(unknown), Thomas R. Klumpp, (unknown), Kenneth F. Mangan	44
16	The Erythroid Leukemias 1998 ·American Journal of Clinical Oncology ·Stuart L. Goldberg, Pierre Noël, Thomas R. Klumpp, Gordon W. Dewald	24
17	Treatment of hepatic veno-occlusive disease with low-dose tissue plasminogen activator: impact on coagulation profile. 1996 ·PubMed ·Steven L. Goldberg, (unknown), A. Koneti Rao, Istvan Redei, Thomas R. Klumpp, Kenneth F. Mangan	12
18	Complications of Peripheral Blood Stem Cell Harvesting: Review of 554 PBSC Leukaphereses 1995 ·Journal of Hematotherapy ·(unknown), Kenneth F. Mangan, Thomas R. Klumpp, J. S. Macdonald, (unknown), (unknown), (unknown)	38
19	Malignant myoepithelioma of the parotid gland: case report and review of the literature 1995 ·The Journal of Laryngology & Otology ·Thomas R. Klumpp, (unknown), Craig L. Silverman, (unknown), I. Bruce Elfenbein, Irving Dardick	17
20	Antibody-mediated neutropenia following bone marrow transplantation 1993 ·International Journal of Clinical & Laboratory Research ·Thomas R. Klumpp	11

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact